Furthermore, given that CRP and its derivatives, including albumin (mGPS and CRP‐to‐albumin ratio), are obligatory measurements in randomized clinical cancer trials,80 used extensively in immunotherapy trials,81, 82 and nutritional support will be increasingly given in this context, it is likely that CRP and its derivatives will become an increasingly important measurement in randomized cancer cachexia clinical trials. The gene discussed is CRP; the disease is cancer.